TapImmune Inc. to Present at BIT's 2nd Annual World Congress on Immunodiseases and Therapy in Guangzhou, China, November 18, 2011
SEATTLE, Oct. 21, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), a biotechnology company developing immunotherapies, today announced that its Chairman and CEO, Dr. Glynn Wilson, is an invited speaker at BIT's 2nd Annual World Congress on Immunodiseases and Therapy to be held in Guangzhou, China, November 18-20, 2011.